86 related articles for article (PubMed ID: 8772657)
1. Quantification of serial tumor glucose metabolism.
Wu HM; Hoh CK; Huang SC; Yao WJ; Phelps ME; Hawkins RA
J Nucl Med; 1996 Mar; 37(3):506-13. PubMed ID: 8772657
[TBL] [Abstract][Full Text] [Related]
2. Quantification of glucose utilization in liver metastases: parametric imaging of FDG uptake with PET.
Messa C; Choi Y; Hoh CK; Jacobs EL; Glaspy JA; Rege S; Nitzsche E; Huang SC; Phelps ME; Hawkins RA
J Comput Assist Tomogr; 1992; 16(5):684-9. PubMed ID: 1522257
[TBL] [Abstract][Full Text] [Related]
3. A modeling method to improve quantitation of fluorodeoxyglucose uptake in heterogeneous tumor tissue.
Wu HM; Huang SC; Choi Y; Hoh CK; Hawkins RA
J Nucl Med; 1995 Feb; 36(2):297-306. PubMed ID: 7830134
[TBL] [Abstract][Full Text] [Related]
4. Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose in the imaging of malignant melanoma.
Gritters LS; Francis IR; Zasadny KR; Wahl RL
J Nucl Med; 1993 Sep; 34(9):1420-7. PubMed ID: 8355058
[TBL] [Abstract][Full Text] [Related]
5. Quantitative PET imaging of bone marrow glucose metabolic response to hematopoietic cytokines.
Yao WJ; Hoh CK; Hawkins RA; Glaspy JA; Weil JA; Lee SJ; Maddahi J; Phelps ME
J Nucl Med; 1995 May; 36(5):794-9. PubMed ID: 7738650
[TBL] [Abstract][Full Text] [Related]
6. Breast imaging with fluorine-18-FDG PET: quantitative image analysis.
Avril N; Bense S; Ziegler SI; Dose J; Weber W; Laubenbacher C; Römer W; Jänicke F; Schwaiger M
J Nucl Med; 1997 Aug; 38(8):1186-91. PubMed ID: 9255146
[TBL] [Abstract][Full Text] [Related]
7. In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET.
Torizuka T; Tamaki N; Inokuma T; Magata Y; Sasayama S; Yonekura Y; Tanaka A; Yamaoka Y; Yamamoto K; Konishi J
J Nucl Med; 1995 Oct; 36(10):1811-7. PubMed ID: 7562048
[TBL] [Abstract][Full Text] [Related]
8. Simplified measurement of deoxyglucose utilization rate.
Hunter GJ; Hamberg LM; Alpert NM; Choi NC; Fischman AJ
J Nucl Med; 1996 Jun; 37(6):950-5. PubMed ID: 8683318
[TBL] [Abstract][Full Text] [Related]
9. Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose.
Gambhir SS; Schwaiger M; Huang SC; Krivokapich J; Schelbert HR; Nienaber CA; Phelps ME
J Nucl Med; 1989 Mar; 30(3):359-66. PubMed ID: 2786939
[TBL] [Abstract][Full Text] [Related]
10. Enhanced FDG-PET tumor imaging with correlation-coefficient filtered influx-constant images.
Zasadny KR; Wahl RL
J Nucl Med; 1996 Feb; 37(2):371-4. PubMed ID: 8667078
[TBL] [Abstract][Full Text] [Related]
11. Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma.
Oriuchi N; Tomiyoshi K; Inoue T; Ahmad K; Sarwar M; Tokunaga M; Suzuki H; Watanabe N; Hirano T; Horikoshi S; Shibasaki T; Tamura M; Endo K
J Nucl Med; 1996 Mar; 37(3):457-62. PubMed ID: 8772644
[TBL] [Abstract][Full Text] [Related]
12. Parametric images of myocardial metabolic rate of glucose generated from dynamic cardiac PET and 2-[18F]fluoro-2-deoxy-d-glucose studies.
Choi Y; Hawkins RA; Huang SC; Gambhir SS; Brunken RC; Phelps ME; Schelbert HR
J Nucl Med; 1991 Apr; 32(4):733-8. PubMed ID: 2013815
[TBL] [Abstract][Full Text] [Related]
13. Lesion-to-background ratio in nonattenuation-corrected whole-body FDG PET images.
Imran MB; Kubota K; Yamada S; Fukuda H; Yamada K; Fujiwara T; Itoh M
J Nucl Med; 1998 Jul; 39(7):1219-23. PubMed ID: 9669398
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of the effect of treatment in patients with liver tumors using 18F-fluorodeoxyglucose PET].
Okazumi S; Enomoto K; Ozaki M; Yamamoto H; Yoshida M; Abe Y; Takayama W; Yamada S; Isono K; Imazeki K
Kaku Igaku; 1989 Jun; 26(6):793-7. PubMed ID: 2796006
[TBL] [Abstract][Full Text] [Related]
15. Positron emission tomography in the clinical evaluation of metastatic cancer.
Fischman AJ
J Clin Oncol; 1996 Mar; 14(3):691-6. PubMed ID: 8622012
[No Abstract] [Full Text] [Related]
16. The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification?
Hamberg LM; Hunter GJ; Alpert NM; Choi NC; Babich JW; Fischman AJ
J Nucl Med; 1994 Aug; 35(8):1308-12. PubMed ID: 8046485
[TBL] [Abstract][Full Text] [Related]
17. Untreated lung cancer: quantification of systematic distortion of tumor size and shape on non-attenuation-corrected 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET scans.
Zasadny KR; Kison PV; Quint LE; Wahl RL
Radiology; 1996 Dec; 201(3):873-6. PubMed ID: 8939245
[TBL] [Abstract][Full Text] [Related]
18. Simple quantification of regional myocardial uptake of fluorine-18-deoxyglucose in the fasting condition.
Tamaki N; Yonekura Y; Kawamoto M; Magata Y; Sasayama S; Takahashi N; Nohara R; Kambara H; Kawai C; Konishi J
J Nucl Med; 1991 Nov; 32(11):2152-7. PubMed ID: 1941154
[TBL] [Abstract][Full Text] [Related]
19. Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer.
Sazon DA; Santiago SM; Soo Hoo GW; Khonsary A; Brown C; Mandelkern M; Blahd W; Williams AJ
Am J Respir Crit Care Med; 1996 Jan; 153(1):417-21. PubMed ID: 8542152
[TBL] [Abstract][Full Text] [Related]
20. An improved method to calculate cerebral metabolic rates of glucose using PET.
Phillips RL; Chen CY; Wong DF; London ED
J Nucl Med; 1995 Sep; 36(9):1668-79. PubMed ID: 7658230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
